Cumyl-BC-HpMeGaClone-221 (Cumyl-NBMeGaClone, Cumyl-BC[2.2.1]HpMeGaClone, SGT-271) is a gamma-carboline derivative which is a synthetic cannabinoid that has been sold as a designer drug. It was first identified in Germany in September 2020.